The United States approved the first medical treatment to redesign the patient’s immune system to attack the cancer cells alone.
The US Food and Drug Administration says they have made a historic decision on world medicine by just approving this treatment.
It is a so-called “live drug”, and it is done separately for every patient. The drug is made from the white blood cells of any patient who is subsequently genetically modified and returned to the patient’s body. By modifying white blood cells, they themselves attack cells of cancer.
As the BBC reports, the drug is made according to the patient’s body and each drug is different, unlike chemotherapy that is universal.
There is, however, a bad side that is certainly left to be noted at the very end, and that is that one such treatment Novartis charges $ 475,000